We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+3.37%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.02B
AUM Growth
-$31.8M
Cap. Flow
+$159M
Cap. Flow %
3.95%
Top 10 Hldgs %
55.91%
Holding
627
New
130
Increased
130
Reduced
70
Closed
208

Top Buys

Rank Stock Value
1
DFS
Discover Financial Services
DFS
+$191M
2
SMAR
Smartsheet Inc.
SMAR
+$188M
3
FYBR
Frontier Communications
FYBR
+$124M
4
SUM
Summit Materials, Inc. Class A Common Stock
SUM
+$95M
5
ALTR
Altair Engineering Inc
ALTR
+$92.6M

Top Sells

Rank Stock Value
1
CTLT
CATALENT, INC.
CTLT
+$234M
2
MRO
Marathon Oil Corporation
MRO
+$222M
3
SRCL
Stericycle Inc
SRCL
+$172M
4
AXNX
Axonics, Inc. Common Stock
AXNX
+$150M
5
PRFT
Perficient Inc
PRFT
+$79.6M

Sector Composition

Rank Sector Weight
1 Technology 28.76%
2 Energy 15.79%
3 Communication Services 7.77%
4 Consumer Staples 7.72%
5 Financials 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELF icon
226
e.l.f. Beauty
ELF
$5.81B
$942K 0.02%
+7,500
New +$900K
RARE icon
227
Ultragenyx Pharmaceutical
RARE
$2.52B
$937K 0.02%
22,284
+1,015
+5% +$50.4K
COO icon
228
Cooper Companies
COO
$14.4B
$930K 0.02%
10,112
+1,826
+22% +$186K
XFOR icon
229
X4 Pharmaceuticals
XFOR
$444M
$928K 0.02%
42,145
-9,500
-18% -$151K
SDGR icon
230
Schrodinger
SDGR
$1.32B
$905K 0.02%
46,914
+18,598
+66% +$361K
IRON icon
231
Disc Medicine
IRON
$2.96B
$904K 0.02%
14,257
-426
-3% -$24.6K
XNCR icon
232
Xencor
XNCR
$1.55B
$897K 0.02%
39,040
+7,040
+22% +$162K
NVNO
233
enVVeno Medical
NVNO
$7.44M
$894K 0.02%
8,458
– –
SLN
234
Silence Therapeutics
SLN
$562M
$887K 0.02%
128,990
+43,289
+51% +$559K
OVID icon
235
Ovid Therapeutics
OVID
$495M
$881K 0.02%
943,416
+315,126
+50% +$353K
VRDN icon
236
Viridian Therapeutics
VRDN
$2.58B
$855K 0.02%
+44,600
New +$970K
MSTR icon
237
Strategy Inc
MSTR
$39.7B
$851K 0.02%
+2,937
New +$884K
UWMC icon
238
UWM Holdings
UWMC
$410M
$839K 0.02%
+143,000
New +$931K
YARW
239
Yarrow Bioscience, Inc. Common Stock
YARW
$117M
$823K 0.02%
+4,916
New +$643K
ONON icon
240
On Holding
ONON
$12.6B
$822K 0.02%
+15,000
New +$795K
ZM icon
241
Zoom
ZM
$30.7B
$816K 0.02%
+10,000
New +$786K
KROS icon
242
Keros Therapeutics
KROS
$211M
$806K 0.02%
50,897
+26,145
+106% +$1.36M
HOG icon
243
PUT
Harley-Davidson
HOG
$2.7B
$805K 0.02%
235,000
– –
MGNI icon
244
Magnite
MGNI
$3.59B
$796K 0.02%
+50,000
New +$734K
TERN
245
DELISTED
Terns Pharmaceuticals
TERN
$777K 0.02%
140,300
+92,300
+192% +$625K
RIG icon
246
PUT
Transocean
RIG
$5.95B
$757K 0.02%
803,400
+400,000
+99% +$1.66M
NGNE icon
247
Neurogene
NGNE
$691M
$748K 0.02%
32,734
+23,907
+271% +$890K
BSX icon
248
Boston Scientific
BSX
$72B
$744K 0.02%
8,334
+1,507
+22% +$133K
LRMR icon
249
Larimar Therapeutics
LRMR
$425M
$730K 0.02%
188,543
-14,240
-7% -$94K
EW icon
250
Edwards Lifesciences
EW
$51.7B
$723K 0.02%
9,760
+2,760
+39% +$193K
8 9
10
11 12

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q4 2024 Portfolio in Review

As of Q4 2024, UBS O'Connor held 627 positions worth $4.02B, down 0.79% from $4.05B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

UBS O'Connor deployed $159M of net new capital in Q4 2024, opening 130 new positions and adding to 130 existing holdings. Its largest new stake was Discover Financial Services: 1,166,698 shares worth $202M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 20% a quarter earlier, followed by Energy and Communication Services.

On the sell side, the largest reduction was US Steel, an estimated $62.2M trimmed.

  • UBS O'Connor's largest Q4 2024 buy was Discover Financial Services: 1,166,698 shares worth $202M.
  • UBS O'Connor added most to Smartsheet Inc. in Q4 2024, an estimated $188M increase.
  • UBS O'Connor's biggest Q4 2024 reduction was US Steel, cutting an estimated $62.2M.
  • UBS O'Connor fully exited CATALENT, INC. in Q4 2024, selling an estimated $234M.
  • UBS O'Connor's ten largest holdings make up 56% of its $4.02B portfolio in Q4 2024.
  • UBS O'Connor opened 130 new positions and closed 208 in Q4 2024.
  • UBS O'Connor's portfolio value fell 0.79% quarter-over-quarter to $4.02B.

Based on UBS O'Connor's 13F filing for Q4 2024, filed 14 Feb 2025.